GlassScriptPhysician profile
Billy R Walton
NPI 1871980995
$3,566.48
in general payments reported to CMS, 2019-2025
13 companies · $1,045 in 2025
The $1,045 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $506 · 2022: $656 · 2023: $627 · 2024: $733 · 2025: $1,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,377 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,376.83 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $611.25 | 2021-2025 | Ingrezza |
| Abbvie INC. | $586.03 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $453.15 | 2021-2025 | Caplyta |
| Lundbeck LLC | $424.62 | 2021-2025 | Abilify Asimtufii, Rexulti |
| Vanda Pharmaceuticals INC. | $318.89 | 2021-2025 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $289.26 | 2021-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $231.40 | 2024-2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $230.47 | 2021-2025 | Austedo Xr, Austedo, Uzedy |
| Axsome Therapeutics, INC. | $151.67 | 2024-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $92.78 | 2022-2024 | Invega Sustenna |
| Supernus Pharmaceuticals, INC. | $83.27 | 2023-2024 | Qelbree, Qelbree |
| Alkermes, INC. | $66.02 | 2025 | Lybalvi, Aristada |
| Indivior INC. | $27.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.